Latest filing published 04 May 2022 for Silverback Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Naomi Hunder: trading record in brief
This profile gathers the share dealings of Naomi Hunder in ARS Pharmaceuticals, Inc., where the filings describe the role as senior executive. The record holds 2 filings, for trades running from 1 February 2022 to 2 May 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 4 May 2022 with a share grant in ARS Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Naomi Hunder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 43,177 shares0Common StockSEC:0001209191-22-027153:0
- 11,250 shares0Common StockSEC:0001209191-22-006436:0
2 of 2 declarations
